Clinical radioimmunotherapy of solid-tumors with chemically modified I-131 labeled chimeric TNT monoclonal antibodies.

被引：0
|
作者：
Jiang, C
Zhoang, G
Cesarman, G
Hu, P
Khawli, LA
Epstein, AL
机构：
[1] Shanghai Med Univ, Shanghai 200032, Peoples R China
[2] Natl Inst Nutr, Mexico City, DF, Mexico
[3] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1087
引用
收藏
页码：247P / 247P
页数：1
相关论文
共 50 条
  • [31] RADIOIMMUNOTHERAPY WITH I-131-LABELED MONOCLONAL-ANTIBODIES 19-9 ANTI-CEA AND OC 125
    BAUM, RP
    CHATAL, JF
    SACCAVINI, JC
    SENEKOWITSCH, R
    HAPP, J
    MANEGOLD, K
    BERTHOLD, F
    HOR, G
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1019 - 1019
  • [32] THYROID RADIATION-DOSIMETRY IN PATIENTS UNDER THERAPY WITH MONOCLONAL-ANTIBODIES (LYM 1) LABELED WITH I-131
    NOGUEIRA, AR
    DENARDO, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 330 - 330
  • [33] RADIOIMMUNOTHERAPY OF COLON-CARCINOMA WITH I-131-LABELED ANTIBODIES, SUCCESSFUL EXPERIMENTAL RESULTS AND CLINICAL DOSIMETRY STUDY
    MACH, JP
    BUCHEGGER, F
    PELEGRIN, A
    YCHOU, M
    RICARD, M
    LUMBROSO, J
    ROUGIER, P
    LASSER, P
    ELIAS, D
    SACCAVINI, JC
    ESCHWEGE, F
    TUBIANA, M
    PARMENTIER, C
    PATHOLOGIE BIOLOGIE, 1990, 38 (08): : 819 - 819
  • [34] RADIOIMMUNOTHERAPY OF HUMAN-COLON CARCINOMA BY I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN NUDE-MICE
    BUCHEGGER, F
    VACCA, A
    SCHREYER, M
    CARREL, S
    MACH, JP
    TUMOR BIOLOGY, 1987, 8 (06) : 350 - 351
  • [35] In vivo evaluation of I-131 labeled monoclonal antibodies (MAb) specific for extracellular domain of prostate specific membrane antigen (PSMA).
    Smith-Jones, PM
    Vallabhajosula, S
    Bastidas, D
    Navarro, V
    Bander, NH
    Goldsmith, SJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 225P - 225P
  • [36] LOCAL TREATMENT OF MALIGNANT GLIOMAS BY DIRECT INFUSION OF SPECIFIC MONOCLONAL-ANTIBODIES LABELED WITH I-131 - COMPARISON OF THE RESULTS OBTAINED IN RECURRENT AND NEWLY-DIAGNOSED TUMORS
    RIVA, P
    ARISTA, A
    FRANCESCHI, G
    FRATTARELLI, M
    STURIALE, C
    RIVA, N
    CASI, M
    ROSSITTI, R
    CANCER RESEARCH, 1995, 55 (23) : S5952 - S5956
  • [37] Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody
    Oriuchi, N
    Higuchi, T
    Alyafei, S
    Zhang, H
    Nakasone, Y
    Watanabe, N
    Kanda, H
    Hashimoto, M
    Inoue, T
    Endo, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1213 - 1213
  • [38] High-dose radioimmunotherapy in refractory B-cell non-Hodgikin lymphoma with I-131-labeled chimeric anti CD-20 (I-131 rituximab): pilot trial
    Cheon, G.
    Kim, S.
    Park, Y.
    Choi, C.
    Lim, S.
    Lee, S.
    Ryu, B.
    Yang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S205 - S205
  • [39] RADIOIMMUNOTHERAPY OF HUMAN-COLON CARCINOMA BY I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN A NUDE-MOUSE MODEL
    BUCHEGGER, F
    VACCA, A
    CARREL, S
    SCHREYER, M
    MACH, JP
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) : 127 - 134
  • [40] Prediction of myelotoxicity after radioimmunotherapy with I-131-labeled anti-carcinoembryonic antigen monoclonal antibodies in patients with colorectal cancers.
    Juweid, M
    Zhang, CH
    Blumenthal, RD
    Sharkey, RM
    Dunlop, D
    Dunn, R
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 970 - 970
12345